Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

ConferenceMedicine and clinical research · Washington, D.C., United States

American Diabetes Association 87th Scientific Sessions 2027

The American Diabetes Association’s 87th Scientific Sessions, held in Washington, D.C. from 18 to 21 June 2027, is the ADA’s annual meeting for diabetes research and care. This guide covers areas consistent with the meeting’s scope, how to check whether an abstract is ready, and what to consider before the regular abstract deadline of 5 January 2027 or the late-breaking window of 25 January to 8 March 2027.

Pubrica InsightsEditorial team, reviewed by a subject specialist
Next deadline
5 January 2027
Last checked
10 November 2026
Organiser
American Diabetes Association
Sources
1
Submit an abstract

Key dates

Abstract deadline
5 January 2027
Full paper deadline
Abstracts only, or not stated
Conference dates
18 June 2027 – 21 June 2027
Details last checked
10 November 2026
Submit an abstract

About the conference

Conference
American Diabetes Association 87th Scientific Sessions 2027
Organiser
American Diabetes Association
Venue
Washington, D.C., United States
Scope
The ADA's annual diabetes research meeting; regular abstracts close 5 January 2027 at 5:00 p.m. ET, and late-breaking abstracts are accepted 25 January to 8 March 2027.
Submission types
Abstracts; confirm formats and word limits on the official page

Topics consistent with the programme

  • Clinical trials of glucose-lowering and cardiometabolic therapies
  • Mechanistic research on beta-cell function and insulin resistance
  • Diabetes technology, including continuous glucose monitoring and insulin delivery
  • Epidemiology and health services research on diabetes care
  • Complications of diabetes affecting the kidney, eye, nerves and heart
  • Behavioural, nutritional and educational interventions in diabetes

Based on the published scope; the official page sets out the full themes and requirements.

Is your work a fit? Check before you submit

  1. The work addresses diabetes, its complications or related metabolic conditions.
  2. The abstract reports results, not only plans, with methods and key findings stated clearly.
  3. The data have not been published in full before the submission, subject to the ADA’s embargo and prior-presentation rules.
  4. The topic category has been selected and abstract rules confirmed on the official abstract page.
  5. The abstract is complete, approved by all co-authors and submitted before 5 January 2027 at 5:00 p.m. ET, or within the late-breaking window if eligible.

Why This Conference Matters

The Scientific Sessions bring together researchers, clinicians and educators across basic, clinical and population diabetes science. Presenting at the meeting allows authors to share findings with a large specialist audience, receive feedback from leaders in the field and connect with potential collaborators. Diabetes care is changing quickly with new therapies, technologies and models of care, and the meeting is a key venue for discussing evidence that may influence practice and future research.

Who Should Submit

Academic backgrounds

  • Endocrinology and diabetology
  • Cardiometabolic medicine
  • Epidemiology and public health
  • Nutrition and behavioural science
  • Biomedical and cell biology research

Institutions and sectors

  • Academic medical centres and universities
  • Pharmaceutical and medical device companies
  • Public health agencies
  • Primary care and community health organisations

What Reviewers Typically Value

  1. Clear, novel results with a well-described design and adequate sample size.
  2. Findings that address an important clinical or scientific question in diabetes.
  3. Concise abstracts in which methods, results and conclusions are consistent with one another.
  4. Work with potential implications for patient care, policy or further research.

Ideas You Could Develop

Real-world outcomes of a new therapyAn analysis of registry or health record data comparing glycaemic and cardiovascular outcomes among people starting a newer glucose-lowering drug.
Glucose monitoring in underserved groupsA study evaluating uptake and outcomes of continuous glucose monitoring among populations with limited access to diabetes technology.
Beta-cell stress mechanismsA laboratory study identifying pathways that contribute to beta-cell dysfunction under metabolic stress.

Your Plan to the Deadline

A suggested schedule working back from 5 January 2027. Adjust it to the stage your work has reached.

  1. By 24 Nov 2026

    Open the official call for abstracts; confirm the tracks, word limit, format and author rules.

  2. By 8 Dec 2026

    Agree the key result, the authors and the presenting author.

  3. By 22 Dec 2026

    Draft the structured abstract to the word limit, with results stated as numbers.

  4. By 29 Dec 2026

    Circulate to co-authors and an independent reader; revise.

  5. By 3 Jan 2027

    Final checks: title, author affiliations, conflicts of interest and track selection.

  6. By 5 Jan 2027

    Submit through the official abstract system before the deadline.

What you gain

  • Feedback from peers working on the same questions.
  • A citable abstract or proceedings paper.
  • Contacts for collaboration, employment and future funding.
  • A step towards a full journal article.

What happens after you submit

  1. Acknowledgement: the abstract system confirms receipt; keep the submission number.
  2. Review: the scientific committee scores abstracts against the track criteria.
  3. Decision: accepted abstracts are assigned to an oral, poster or e-poster session.
  4. Registration: presenting authors usually must register by a stated date.
  5. Publication: accepted abstracts or papers may appear in the conference proceedings or journal supplement.

What the Organisers Are Looking For

The ADA invites abstracts reporting new research across the breadth of diabetes science and care. Organisers are likely to look for clearly reported, original data with relevance to understanding, preventing or treating diabetes and its complications. Authors should review the official abstract page for categories, formatting, embargo rules and eligibility for the late-breaking round, which runs from 25 January to 8 March 2027.

Read the official pageThis guide summarises the opportunity. Confirm deadlines, eligibility and requirements on the official page before you plan your work, and record the date you checked it.Open the official page

Expert help

How Pubrica Can Help

Pubrica’s subject specialists can help you prepare the abstract, full paper, poster or slides, planned back from the deadline. You remain the author of your work.

Abstract writingA structured abstract written to the conference’s word limit and format. Full paper writingFull conference papers written to the proceedings template. Poster preparationScientific posters designed to the conference’s size and layout rules. Presentation slidesOral presentation slides prepared for the allotted time. Editing and proofreadingSubject-specialist editing of abstracts and papers before submission. BiostatisticsStatistical analysis and review of results.
Go to the official page

FAQs

Questions Researchers Ask

The next published deadline is 5 January 2027. Dates can change, so confirm them on the official page before you plan your work.

Abstracts are generally expected to report results rather than planned work, so incomplete studies may not be accepted. Authors whose data will be ready later may consider whether the late-breaking window from 25 January to 8 March 2027 applies. Confirm the rules on the official abstract page.

The official page lists abstract submission; check it for any full paper or proceedings option.

Yes. Pubrica’s specialists can review, write, edit and format your abstract, paper, poster or slides. You remain the author and the person responsible for the submission.

Sources

  1. American Diabetes Association. (2026). American Diabetes Association 87th Scientific Sessions 2027. Retrieved 10 November 2026, from https://professional.diabetes.org/content-page/abstracts-faq-0

How to cite this page

Pubrica Insights. (2026). American Diabetes Association 87th Scientific Sessions 2027. Pubrica. https://pubrica.com/insights/calls-and-conferences/american-diabetes-association-87th-scientific-sessions-2027/

  • Diabetes
  • ADA 2027
  • Endocrinology
  • Cardiometabolic
  • Abstracts

Other Open Conferences

Closes 16 November 202636th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2027)Australia Closes 18 November 2026ESCMID Global 2027Sweden Closes 19 November 2026ESC Preventive Cardiology 2027Portugal

All calls, conferences and fundingAbstract writing

ADA 2027Next deadline 5 January 2027

Official page
Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.